HRES 1200
Supporting the designation of March 2026 as Endometriosis Awareness Month.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This resolution seeks to raise awareness about endometriosis, a chronic gynecological disease affecting approximately 1 in 10 women of reproductive age. It highlights the challenges women face in diagnosis, the significant impact on their quality of life, and the need for increased research and improved healthcare access. The resolution encourages public awareness and support for endometriosis research and education.
Key provisions
- Designates March 2026 as Endometriosis Awareness Month.
- Recognizes the need for early detection and treatment of endometriosis.
- Calls for increased education for healthcare providers.
- Encourages culturally competent care for women with endometriosis.
- Supports and funds endometriosis research.
- Promotes the development of more effective treatments.
- Aims to increase fertility options for women with endometriosis.
- Urges the pursuit of a cure for endometriosis.
Who is affected
- Women
- Gynecological patients
- Patients with chronic pain
- Individuals with reproductive health concerns
Notable changes
- Establishes a designated awareness month to increase public understanding.
- Highlights the significant diagnostic delays and associated impact on quality of life.
- Emphasizes the need for increased research funding and treatment options.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
119th CONGRESS — 2d Session
H. RES. 1200
IN THE HOUSE OF REPRESENTATIVES
RESOLUTION
Supporting the designation of March 2026 as Endometriosis Awareness Month.
Whereas endometriosis is a disease in which the type of tissue that normally grows in the uterus (the endometrium) also grows outside of the uterus;
Whereas endometriosis is one of the most common gynecological diseases in women, and occurs in 1 in 10 women of reproductive age;
Whereas the cause of endometriosis is not known, but risk factors include—
menstrual cycles that started at an early age;
menstrual cycles that are short; and
periods that are heavy and last more than 7 days;
Whereas, for many women, the only way currently available to be certain of an endometriosis diagnosis is to have a surgical procedure known as a laparoscopy;
Whereas women experience a delay from three to eleven years between the first symptoms of pain and the final endometriosis diagnosis, which can lead to lower quality of life and high medical costs;
Whereas, for many girls and women, endometriosis is a lifelong chronic disease that can affect relationships, school, work, fertility, and daily life;
Whereas the primary symptoms of endometriosis include pain and infertility, and many with endometriosis live with debilitating, chronic pain;
Whereas approximately 75 percent of women with endometriosis experience a misdiagnosis;
Whereas the management of symptoms of endometriosis may include surgery, gonadotropin-releasing hormone (GnRH) antagonists, and many other medical treatments;
Whereas endometriosis is associated with increased health care costs and poses a substantial burden to patients in the health care system;
Whereas, in the United States, the estimated average direct health care cost associated with endometriosis per patient is more than $13,000 per year;
Whereas 40 percent of women with endometriosis report impaired career growth due to endometriosis, and approximately 50 percent of women with endometriosis experience a decreased ability to work;
Whereas the Centers for Disease Control and Prevention found that the average number of bed days
for patients with endometriosis was 18 days per year;
Whereas women with endometriosis can lose 11 hours per workweek through lost productivity;
Whereas the physical and psychological impact of endometriosis affects all domains of life, including social life, relationships, and work;
Whereas medical societies and patient groups have expressed the need for greater public attention and updated resources targeted to public education about this unmet health need for women;
Whereas there is a need for more research and updated guidelines to treat endometriosis;
Whereas there is an ongoing need for additional clinical research and treatment options to manage this debilitating disease; and
Whereas there is no known cure for endometriosis: Now, therefore, be it
That the House of Representatives—
strongly supports the goals and ideals of Endometriosis Awareness Month;
recognizes the need for early detection and treatment of endometriosis, increased education for health care providers, and more culturally competent care;
remains committed to supporting and funding endometriosis research for more effective treatments, increasing fertility, and, ultimately, a cure; and
encourages the people of the United States to observe the month with appropriate awareness and educational activities.